2000
Recent Advances in Respiratory Care of the Term Neonate
GROSS I. Recent Advances in Respiratory Care of the Term Neonate. Annals Of The New York Academy Of Sciences 2000, 900: 151-158. PMID: 10818401, DOI: 10.1111/j.1749-6632.2000.tb06225.x.ChaptersConceptsConventional ventilationLong-term neurologic outcomeHours of diagnosisNear-term infantsPersistent pulmonary hypertensionNitric oxide therapyChronic lung diseaseHigh-frequency ventilationHigh-frequency ventilatorNeurologic outcomePulmonary hypertensionTerm neonatesMembrane oxygenationRespiratory distressLung diseaseRespiratory careMajor causeTreatment regimesVentilationMorbidityInfantsTherapyMortalityHypertensionCyanosis
1993
Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences.
Moya F, Gross I. Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars In Perinatology 1993, 17: 267-74. PMID: 8140441.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAntenatal steroidsPostnatal surfactantSurfactant therapyPostnatal surfactant therapyRespiratory distress syndromeSteroid therapyHormonal therapyDistress syndromePremature infantsTherapyNumber of centersEnd pointRoutine useSteroidsTRHMaturation profileApparent benefitPatientsInfantsDeathTerms of RDCLDWidespread useSyndromeComparable data
1989
Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation.
Dworetz A, Moya F, Sabo B, Gladstone I, Gross I. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. Pediatrics 1989, 84: 1-6. PMID: 2740158, DOI: 10.1542/peds.84.1.1.Peer-Reviewed Original ResearchConceptsPersistent pulmonary hypertensionPulmonary hypertensionExtracorporeal membrane oxygenation therapyCorresponding survival figuresMembrane oxygenation therapyExtracorporeal membrane oxygenationRecords of infantsSurvival of infantsConservative therapyMembrane oxygenationOxygenation therapySurvival figuresRetrospective evaluationMortality rateHypertensionECMOTherapyPatientsInfantsConservative approachSurvivalEarly periodHyperventilationCriteriaMainstay
1988
Prevention of respiratory distress syndrome.
Moya F, Gross I. Prevention of respiratory distress syndrome. Seminars In Perinatology 1988, 12: 348-58. PMID: 3146813.Chapters
1987
The Biochemistry of Fetal Lung Development
Kresch M, Gross I. The Biochemistry of Fetal Lung Development. Clinics In Perinatology 1987, 14: 481-507. PMID: 3311536, DOI: 10.1016/s0095-5108(18)30747-4.ChaptersConceptsSurfactant therapyLung complianceLung maturationAdministration of betamethasoneEffects of glucocorticoidsFetal lung developmentNumber of alveoliGlucocorticoid therapyFetal rabbitsLung developmentTherapyAnimal dataTissue complianceHormonal enhancementAdditive effectAdministrationComplianceMaturationRDSMorbidityBetamethasoneGlucocorticoidsLungMortalitySteroids
1984
COMBINED HORMONAL THERAPY MAY DECREASE THE TIME NEEDED FOR INDUCTION OF LUNG SURFACTANT PRODUCTION
Moya F, Gross I. COMBINED HORMONAL THERAPY MAY DECREASE THE TIME NEEDED FOR INDUCTION OF LUNG SURFACTANT PRODUCTION. Pediatric Research 1984, 18: 142-142. DOI: 10.1203/00006450-198404001-00296.Peer-Reviewed Original ResearchLung surfactant productionHormonal therapyFetal ratsDay 20Surfactant productionPregnant Sprague-Dawley ratsFetal lung maturationSprague-Dawley ratsCombination of hormonesMaternal administrationCombined therapyLung maturationMaternal injectionLung mincesThyroid hormonesCholine incorporationSurfactant synthesisTherapyRatsStatistical significanceRecent evidenceCorticosteroidsBetamethasoneFetusesAdditive effect